| Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis P Savas, B Virassamy, C Ye, A Salim, CP Mintoff, F Caramia, R Salgado, ... Nature medicine 24 (7), 986-993, 2018 | 702 | 2018 |
| Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers M Yan, N Jene, D Byrne, EKA Millar, SA O'Toole, CM McNeil, GJ Bates, ... Breast Cancer Research 13, 1-10, 2011 | 188 | 2011 |
| Comparison of four PD-L1 immunohistochemical assays in lung cancer S Hendry, DJ Byrne, GM Wright, RJ Young, S Sturrock, WA Cooper, ... Journal of Thoracic Oncology 13 (3), 367-376, 2018 | 145 | 2018 |
| Preoperative β-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial JG Hiller, SW Cole, EM Crone, DJ Byrne, DM Shackleford, JMB Pang, ... Clinical Cancer Research 26 (8), 1803-1811, 2020 | 107 | 2020 |
| Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer S Deb, I Johansson, D Byrne, C Nilsson, L Constable, ML Fjällskog, ... Modern Pathology 27 (9), 1223-1230, 2014 | 68 | 2014 |
| Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic FeaturesImmune Cells and Genomics in DCIS S Hendry, JMB Pang, DJ Byrne, SR Lakhani, MC Cummings, IG Campbell, ... Clinical Cancer Research 23 (17), 5210-5217, 2017 | 63 | 2017 |
| Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women E Tilch, T Seidens, S Cocciardi, LE Reid, D Byrne, PT Simpson, ... Breast cancer research and treatment 143, 385-392, 2014 | 62 | 2014 |
| Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma P Blombery, E Thompson, GL Ryland, R Joyce, DJ Byrne, C Khoo, S Lade, ... Oncotarget 9 (90), 36126, 2018 | 60 | 2018 |
| Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer JMB Pang, P Savas, AP Fellowes, GM Arnau, T Kader, R Vedururu, ... Modern Pathology 30 (7), 952-963, 2017 | 58 | 2017 |
| A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer F Day, A Muranyi, S Singh, K Shanmugam, D Williams, D Byrne, K Pham, ... Targeted oncology 10, 99-109, 2015 | 56 | 2015 |
| COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment D Generali, FM Buffa, S Deb, M Cummings, LE Reid, M Taylor, D Andreis, ... British journal of cancer 111 (1), 46-54, 2014 | 55 | 2014 |
| High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot SP Keam, H Halse, T Nguyen, M Wang, NVK Losio, C Mitchell, F Caramia, ... Journal for immunotherapy of cancer 8 (1), 2020 | 47 | 2020 |
| Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue T Kader, DL Goode, SQ Wong, J Connaughton, SM Rowley, L Devereux, ... Genome medicine 8 (1), 1-13, 2016 | 47 | 2016 |
| Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases R Agarwal, S Lade, D Liew, TM Rogers, D Byrne, F Feleppa, S Juneja, ... Journal of clinical pathology 69 (3), 266-270, 2016 | 44 | 2016 |
| CCL27/CCL28–CCR10 chemokine signaling mediates migration of lymphatic endothelial cells T Karnezis, RH Farnsworth, NC Harris, SP Williams, C Caesar, DJ Byrne, ... Cancer Research 79 (7), 1558-1572, 2019 | 38 | 2019 |
| Estrogen receptor subtypes dictate the proliferative nature of the mammary gland GV Dall, S Hawthorne, Y Seyed-Razavi, J Vieusseux, W Wu, ... Journal of Endocrinology 237 (3), 323-336, 2018 | 37 | 2018 |
| Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion CR McEvoy, H Xu, K Smith, D Etemadmoghadam, H San Leong, ... The Journal of clinical investigation 129 (5), 1940-1945, 2019 | 35 | 2019 |
| Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer N Li, S McInerny, M Zethoven, D Cheasley, BWX Lim, SM Rowley, ... JNCI: Journal of the National Cancer Institute 111 (12), 1332-1338, 2019 | 30 | 2019 |
| Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer KT Huang, EA Takano, T Mikeska, DJ Byrne, A Dobrovic, SB Fox Breast cancer research and treatment 130, 319-329, 2011 | 29 | 2011 |
| SP142 PD-L1 scoring shows high interobserver and intraobserver agreement in triple-negative breast carcinoma but overall low percentage agreement with other PD-L1 clones SP263 … JMB Pang, B Castles, DJ Byrne, P Button, S Hendry, SR Lakhani, ... The American journal of surgical pathology 45 (8), 1108, 2021 | 27 | 2021 |
